Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
132.4 USD | +1.37% | +3.57% | +15.77% |
Apr. 26 | Wolfe Adjusts Price Target on Xylem to $145 From $143 | MT |
Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 39.34 and 33.26 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.85 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.77% | 32.01B | A | ||
+11.73% | 82.35B | A- | ||
+20.17% | 71.09B | B | ||
+20.89% | 37.73B | B- | ||
+9.19% | 27.2B | B- | ||
+3.18% | 26.74B | C+ | ||
+4.22% | 26B | B+ | ||
+16.93% | 25.5B | B+ | ||
+17.14% | 24.76B | B | ||
+17.30% | 17.84B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- XYL Stock
- Ratings Xylem Inc.